Integra LifeSciences [IART] vs Artivion [AORT] Detailed Stock Comparison

Integra LifeSciences Holdings Corporation

NASDAQ
Loading...

Artivion Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Integra LifeSciences Holdings Corporation wins in 13 metrics, Artivion Inc. wins in 7 metrics, with 0 ties. Integra LifeSciences Holdings Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Integra LifeSciences Holdings Corporation Artivion Inc. Better
P/E Ratio (TTM) 66.48 179.71 Integra LifeSciences Holdings Corporation
Price-to-Book Ratio 0.79 4.03 Integra LifeSciences Holdings Corporation
Debt-to-Equity Ratio 195.01 57.67 Artivion Inc.
PEG Ratio -0.61 -1.59 Integra LifeSciences Holdings Corporation
EV/EBITDA 8.70 36.67 Integra LifeSciences Holdings Corporation
Profit Margin (TTM) -31.58% 2.21% Artivion Inc.
Operating Margin (TTM) 12.44% 8.09% Integra LifeSciences Holdings Corporation
EBITDA Margin (TTM) 12.44% 8.09% Integra LifeSciences Holdings Corporation
Return on Equity -39.90% 2.70% Artivion Inc.
Return on Assets (TTM) 2.39% 2.34% Integra LifeSciences Holdings Corporation
Free Cash Flow (TTM) $-45.25M $839,000 Artivion Inc.
1-Year Return 26.70% -24.98% Integra LifeSciences Holdings Corporation
Price-to-Sales Ratio (TTM) 0.50 4.15 Integra LifeSciences Holdings Corporation
Enterprise Value $2.59B $1.97B Integra LifeSciences Holdings Corporation
EV/Revenue Ratio 1.58 4.47 Integra LifeSciences Holdings Corporation
Gross Profit Margin (TTM) 50.78% 63.06% Artivion Inc.
Revenue per Share (TTM) $21 $10 Integra LifeSciences Holdings Corporation
Earnings per Share (Diluted) $-6.74 $0.21 Artivion Inc.
Beta (Stock Volatility) 1.07 1.62 Integra LifeSciences Holdings Corporation
Short % of Float 15.66% 4.13% Artivion Inc.

Integra LifeSciences Holdings Corporation vs Artivion Inc. Stock Performance Analysis

Loading Price Chart...

IART
AORT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Integra LifeSciences Holdings Corporation2.74%5.99%51.17%52.46%19.35%34.05%
Artivion Inc.0.78%-9.58%-42.08%-46.71%-54.75%-53.71%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Integra LifeSciences Holdings Corporation26.70%-58.81%-76.26%-57.80%-32.49%-15.84%
Artivion Inc.-24.98%45.13%-23.19%88.21%317.89%366.18%

Performance & Financial Health Analysis: Integra LifeSciences Holdings Corporation vs Artivion Inc.

MetricIARTAORT
Market Information
Market Cap i$804.31M$1.83B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i754,949273,552
90 Day Avg. Volume i818,793406,554
Last Close$16.10$20.58
52 Week Range$8.70 - $16.70$19.16 - $48.25
% from 52W High-3.59%-57.35%
All-Time High$77.40 (Apr 26, 2021)$48.25 (Dec 17, 2025)
% from All-Time High-79.20%-57.35%
Growth Metrics
Quarterly Revenue Growth-0.02%0.19%
Quarterly Earnings Growth-0.02%0.19%
Financial Health
Profit Margin (TTM) i-0.32%0.02%
Operating Margin (TTM) i0.12%0.08%
Return on Equity (TTM) i-0.40%0.03%
Debt to Equity (MRQ) i195.0157.67
Cash & Liquidity
Book Value per Share (MRQ)$13.40$9.37
Cash per Share (MRQ)$3.38$1.36
Operating Cash Flow (TTM) i$50.38M$39.88M
Levered Free Cash Flow (TTM) i$44.46M$-20,097,624
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Integra LifeSciences Holdings Corporation vs Artivion Inc.

MetricIART (Apr 24, 2026)AORT (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i66.48179.71
Forward P/E i4.1132.65
PEG Ratio i-0.61-1.59
Price to Sales (TTM) i0.504.15
Price to Book (MRQ) i0.794.03
Market Capitalization
Market Capitalization i$804.31M$1.83B
Enterprise Value i$2.59B$1.97B
Enterprise Value Metrics
Enterprise to Revenue i1.584.47
Enterprise to EBITDA i8.7036.67
Risk & Other Metrics
Beta i1.071.62
Book Value per Share (MRQ) i$13.40$9.37

Financial Statements Comparison: Integra LifeSciences Holdings Corporation vs Artivion Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIART (2025)AORT (2025)
Revenue/Sales i1.64B441.33M
Cost of Goods Sold i803.63M157.10M
COGS % of Revenue i49.1%35.6%
Gross Profit i831.62M284.23M
Gross Margin i50.9%64.4%
Research & Development i98.97M30.99M
Operating Income (EBIT) i18.00M26.75M
Operating Margin i1.1%6.1%
EBITDA i185.95M59.48M
EBITDA Margin i11.4%13.5%
Pre-Tax Income i-563.50M14.78M
Pre-Tax Income % of Revenue i-34.5%3.3%
Income Tax i-47.03M5.01M
Income Tax % of Revenue i-2.9%1.1%
Net Income (Profit) i-516.47M9.77M
Profit Margin i-31.6%2.2%

Balance Sheet & Liquidity Metrics

MetricIART (2025)AORT (2025)
Cash & Equivalents i235.05M64.91M
Total Current Assets i1.16B358.08M
Total Current Assets % of Revenue i70.9%81.1%
Total Current Liabilities i455.98M101.56M
Total Current Liabilities % of Revenue i27.9%23.0%
Long-Term Debt i1.89B252.24M
Long-Term Debt % of Revenue i115.7%57.2%
Total Shareholders Equity i1.04B448.23M
Retained Earnings i423.44M-51.50M
Retained Earnings % of Revenue i25.9%-11.7%
Property, Plant & Equipment i140.57M34.70M

Cash Flow Statement Comparison

MetricIART (2025)AORT (2025)
Operating Cash Flow i-458.67M41.11M
Operating Cash Flow % of Revenue i-28.0%9.3%
Capital Expenditures i-81.44MN/A
Free Cash Flow i-45.25M839,000
FCF Margin i-2.8%0.2%
Debt Repayment i-669.89M-2.46M
Common Stock Repurchase i-221,0000

Short Interest & Institutional Ownership Analysis

MetricIARTAORT
Shares Short i8.86M1.67M
Short Ratio i10.734.28
Short % of Float i15.66%4.13%
Shares Outstanding i77.89M47.84M
Float Shares i58.96M45.40M
% Held by Insiders i14.38%4.52%
% Held by Institutions i97.96%91.48%
% Held by Public i-12.34%4.00%

Dividend Analysis & Yield Comparison: Integra LifeSciences Holdings Corporation vs Artivion Inc.

MetricIARTAORT
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A